We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+3.06%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$4.68B
AUM Growth
-$270M
(-5.5%)
Cap. Flow
-$364M
Cap. Flow
% of AUM
-7.78%
Top 10 Holdings %
Top 10 Hldgs %
11.36%
Holding
1,103
New
193
Increased
369
Reduced
317
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$25.2M |
| 2 |
Ashland
ASH
|
+$17.2M |
| 3 |
IBM
IBM
|
+$17.1M |
| 4 |
Madison Square Garden
MSGS
|
+$16.7M |
| 5 |
Valero Energy
VLO
|
+$16.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$35.9M |
| 2 |
Qualcomm
QCOM
|
+$29M |
| 3 |
BCR
CR Bard Inc.
BCR
|
+$27.5M |
| 4 |
Agilent Technologies
A
|
+$26.4M |
| 5 |
Northrop Grumman
NOC
|
+$25.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.21% |
| 2 | Financials | 19.14% |
| 3 | Healthcare | 11.97% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZNGA
51
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $22.5M | 0.48% |
6,193,866
-602,162
| -9% | -$1.98M |
|
52
Gilead Sciences
GILD
$162B
| $22.1M | 0.47% |
312,654
-236,100
| -43% | -$15.7M |
|
53
Baxter International
BAX
$11.2B
| $21.8M | 0.47% |
359,400
+23,560
| +7% | +$1.34M |
|
54
Cable One
CABO
$211M
| $21.7M | 0.46% |
30,476
-332
| -1% | -$228K |
|
|
TECD
55
DELISTED
Tech Data Corp
TECD
| $21.7M | 0.46% |
214,501
+148,691
| +226% | +$14.3M |
|
56
Chevron
CVX
$387B
| $21.2M | 0.45% |
203,600
+28,470
| +16% | +$3.02M |
|
57
Viavi Solutions
VIAV
$10.3B
| $20.4M | 0.44% |
1,941,256
-7,651
| -0.4% | -$82.4K |
|
58
Archer Daniels Midland
ADM
$41.6B
| $20.4M | 0.44% |
492,104
-69,520
| -12% | -$2.98M |
|
59
Walt Disney
DIS
$161B
| $20.3M | 0.43% |
191,100
+99,460
| +109% | +$10.9M |
|
60
Capital One
COF
$123B
| $20.2M | 0.43% |
244,820
+78,680
| +47% | +$6.39M |
|
61
Textron
TXT
$16.2B
| $20M | 0.43% |
424,455
-103,380
| -20% | -$4.86M |
|
|
62
Valero Energy
VLO
$90.7B
| $19.9M | 0.43% |
295,680
+248,520
| +527% | +$16.1M |
|
63
Rockwell Automation
ROK
$51.3B
| $19.5M | 0.42% |
120,617
+99,120
| +461% | +$15.6M |
|
64
TJX Companies
TJX
$170B
| $19.4M | 0.42% |
538,420
+188,800
| +54% | +$7.12M |
|
65
Emcor
EME
$34.2B
| $19.2M | 0.41% |
293,342
+10,870
| +4% | +$699K |
|
66
NOV
NOV
$7.22B
| $19.1M | 0.41% |
579,124
+268,580
| +86% | +$9.27M |
|
67
Assurant
AIZ
$13.6B
| $19.1M | 0.41% |
183,843
+37,310
| +25% | +$3.72M |
|
68
Hartford Financial Services
HIG
$39B
| $19M | 0.41% |
361,289
-44,500
| -11% | -$2.21M |
|
|
SNV
69
DELISTED
Synovus
SNV
| $18.9M | 0.41% |
428,311
+226,839
| +113% | +$9.53M |
|
70
Keurig Dr Pepper
KDP
$40.4B
| $18.8M | 0.4% |
205,923
-14,710
| -7% | -$1.38M |
|
71
Northern Trust
NTRS
$21.9B
| $18.6M | 0.4% |
191,472
-6,168
| -3% | -$555K |
|
|
ETFC
72
DELISTED
E*Trade Financial Corporation
ETFC
| $18.4M | 0.39% |
484,221
+30,050
| +7% | +$1.06M |
|
73
Yum! Brands
YUM
$40.6B
| $18.3M | 0.39% |
248,530
+177,380
| +249% | +$12.3M |
|
|
AAN.A
74
DELISTED
The Aaron's Company Inc Class A
AAN.A
| $18.3M | 0.39% |
469,277
-55,777
| -11% | -$2.17M |
|
75
Jabil
JBL
$33.7B
| $18M | 0.39% |
618,199
+10,140
| +2% | +$298K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2017 Portfolio in Review
As of Q2 2017, Jacobs Levy Equity Management held 1,103 positions worth $4.68B, down 5.5% from $4.95B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jacobs Levy Equity Management withdrew a net $364M in Q2 2017, closing 187 positions and reducing 317 holdings. Its most notable exit was CVS Health, an estimated $35.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Jacobs Levy Equity Management opened a new position in Humana worth $26.8M.
- Jacobs Levy Equity Management's largest Q2 2017 buy was Humana: 111,320 shares worth $26.8M.
- Jacobs Levy Equity Management added most to Madison Square Garden in Q2 2017, an estimated $16.7M increase.
- Jacobs Levy Equity Management's biggest Q2 2017 reduction was Agilent Technologies, cutting an estimated $26.4M.
- Jacobs Levy Equity Management fully exited CVS Health in Q2 2017, selling an estimated $35.9M.
- Jacobs Levy Equity Management's ten largest holdings make up 11% of its $4.68B portfolio in Q2 2017.
- Jacobs Levy Equity Management opened 193 new positions and closed 187 in Q2 2017.
- Jacobs Levy Equity Management's portfolio value fell 5.5% quarter-over-quarter to $4.68B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2017, filed 14 Aug 2017.